TL;DR
It is demonstrated that EC cells exhibit increased aerobic glycolysis, as confirmed by bulk transcriptomics, extracellular lactate measurements, RT-PCR, and immunohistochemistry, and the IL-6 axis is highlighted as a therapeutic target, offering new strategies for treating EC by disrupting metabolic-immune crosstalk.
AI-generated by Semantic Scholar
Authors
Xiaodie Liu, Heming Sun, Jing Liang, Huan Yu, Ming Xue, Yuebo Li, Wenhui Li, Ying Xu, Bin Ling, Dingqing Feng